Intracerebral Hemorrhage
Conditions
Brief summary
This is a retrospective observational study to investigate the clinical, analytical and neuroimaging data generated during routine clinical management of intracerebral hemorrhage. The study will review the data from about 500 patients attended during the last ten years in the Neurology Department of Hospital Parc Taulí de Sabadell. The aim is to measure the size of the lesion in neuroimage (TC and MRI), the edema, the alterations in diffusion weighted images and to correlate this data with clinical parameters and analytical measurements. With this approach investigators plan to investigate the incidence of hematoma growth, the role of perilesional edema and diffusion changes, and the relation between neuroimaging findings and clinical outcome. The study also try to establish significant correlations between clinical and analytical data, the clinical outcome and and the magnitude of changes in neuroimaging.
Interventions
OTHERNo intervention
This observational study is not focused on therapeutic intervention
Sponsors
Parc Taulí Hospital Universitari
Universitat Autonoma de Barcelona
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients who have been attended at the Hospital Parc Taulí for the last 10 years after presenting an intraparenchymal hemorrhage. * The patients have had to undergo a computed tomography at the admission and a cranial magnetic resonance during the hospitalization in the time course specified in point in the protocol * The patients must present in their clinical story the analytical determinations detailed in the protocol.
Exclusion criteria
* Intracerebral hemorrhage secondary to head trauma * Intracerebral hemorrhage secondary to neoplasm
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between hematoma growth and analytical parameters | 2 days | Determine the analytical parameters related with hematoma growth |
| Perilesional edema | 2 days | Size of edema measured in FLAIR sequences |
| Hematoma growth | 2 days | Difference of hematoma size between CT conducted at admission and MRI conducted during follow up |
| Correlation between hematoma growth and clinical paramenters | 2 days | Determine the clinical parameters related with hematoma growth |
| Correlation between clinical parameters and the size of edema measured in FLAIR sequences | 2 days | Determine the relationship between clinical parameters and the size of edema |
| Correlation between analytical parameters and the size of edema measured in FLAIR sequences | 2 days | Determine the relationship between analytical parameters and the size of edema |
| Alterations in DWI | 2 days | Size of alterations in diffusion weighted image |
| Correlation between clinical parameters and the size of alterations in DWI | 2 days | Determine the relationship between clinical parameters and the size of alterations in DWI |
| Correlation between analytical parameters and the size of alterations in DWI | 2 days | Determine the relationship between analytical parameters and the size of alterations in DWI |
| Correlation between hematoma growth and clinical outcome | 1 month | Determine the impact of hematoma growth on clinical outcome |
| Correlation between perilesional edema size and clinical outcome | 1 month | Determine the relationship between the size of edema and clinical outcome |
| Correlation between the size of DWI alterations and clinical outcome | 1 month | Determine the relationship between the size of DWI alterations and clinical outcome |
| Correlation between the clinical parameters and clinical outcome | 1 month | Determine the relationship between the clinical parametes and clinical outcome |
| Correlation between the analyticial parameters and clinical outcome | 1 month | Determine the relationship between the analytical parametes and clinical outcome |
Countries
Spain
Outcome results
None listed